Generic Patanol for Seasonal Allergic Conjunctivitis Approved - Pharmacy Times
Generic Patanol for Seasonal Allergic Conjunctivitis ApprovedPharmacy TimesThe FDA has given final approval to Aurobindo Pharma Limited to manufacture and market olopatadine hydrochloride ophthalmic solution, a generic equivalent of Alcon Laboratories Inc's Patanol drops.
Novartis's Alcon Wins Bid to Block Apotex's Generic PatanolBloombergThe ruling means the order preventing Apotex from selling generic Patanol remains in effect, Eric Althoff, a spokesman for Novartis, said in a statement.
Novartis's Alcon Unit Wins Patent Fight Over Generic Patanol - Bloomberg
Novartis's Alcon Unit Wins Patent Fight Over Generic PatanolBloombergPatanol, whose active ingredient is olopatadine hydrochloride, is the top-selling medicine to treat allergic conjunctivitis, the most common type of allergic disease in the eye.
Novartis delivered solid Q1 despite Gleevec loss of exclusivity; investing behind new launches for long-term growth - Yahoo Finance UK
Novartis delivered solid Q1 despite Gleevec loss of exclusivity; investing behind new launches for long-term growthYahoo Finance UKGeneric impact on the Ophthalmic Pharmaceuticals products transferred from Alcon, mainly Patanol, negatively impacted Pharmaceuticals sales growth in the quarter.
REFILE-No quick fix seen for Novartis's troubled Alcon unit - Reuters
REFILE-No quick fix seen for Novartis's troubled Alcon unitReutersIn addition to Travatan Z, Patanese, one of Alcon's allergy drugs, has gone off patent, while Patanol and Pataday also face imminent generic competition, he said.